Insider · CIK 0001819688
William D. Turner
Files at VERA (Vera Therapeutics, Inc.). First filing Dec 4, 2025, latest Feb 25, 2026.
William D. Turner files SEC Form 4 as officer at VERA (Vera Therapeutics, Inc.). Since Dec 4, 2025, William D. Turner has reported 0 open-market buys worth $0 and 4 open-market sells worth $1.4M, the latest filed on Feb 25, 2026.
A track record needs three past buys with six months of prices behind them; William D. Turner has 0, so none is measured yet.
The newest scored trade: sold $92k of VERA on Feb 23, 2026, filed Feb 25, 2026, scored 39 (weak). In the last 12 months: 0 buys worth $0 and 4 sells worth $1.4M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VERA: Vera Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | Vera Therapeutics, Inc. | $92k 2,187 shares | -5% | +123% from low-24% from high | |
| 8Weak | Vera Therapeutics, Inc. | $501k 10,000 shares | -31% | +161% from low-1% from high | |
| 7Weak | Vera Therapeutics, Inc. | $453k 10,000 shares | -31% | +139% from low-5% from high | |
| 14Weak | Vera Therapeutics, Inc. | $400k 10,000 shares | -31% | +119% from low-17% from high |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | VERA Vera Therapeutics, Inc. | SOpen-market sale Class A Common Stock | -2,187 | $41.98 | $92k | 45,313 | Feb 25, 2026 |
| Feb 4, 2026 | VERA Vera Therapeutics, Inc. | AGrant or award Class A Common Stock | +25,000 | $0.00 | $0 | 47,500 | Feb 6, 2026 |
| Feb 4, 2026 | VERA Vera Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Feb 6, 2026 |
| Dec 15, 2025 | VERA Vera Therapeutics, Inc. | MOption exercise Class A Common Stock10b5-1 | +10,000 | $15.53 | $155k | 32,500 | Dec 17, 2025 |
| Dec 15, 2025 | VERA Vera Therapeutics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -10,000 | $50.08 | $501k | 22,500 | Dec 17, 2025 |
| Dec 15, 2025 | VERA Vera Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 245,000 | Dec 17, 2025 |
| Dec 8, 2025 | VERA Vera Therapeutics, Inc. | MOption exercise Class A Common Stock10b5-1 | +10,000 | $15.53 | $155k | 32,500 | Dec 10, 2025 |
| Dec 8, 2025 | VERA Vera Therapeutics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -10,000 | $45.31 | $453k | 22,500 | Dec 10, 2025 |
| Dec 8, 2025 | VERA Vera Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 255,000 | Dec 10, 2025 |
| Dec 3, 2025 | VERA Vera Therapeutics, Inc. | MOption exercise Class A Common Stock10b5-1 | +10,000 | $15.53 | $155k | 32,500 | Dec 4, 2025 |
| Dec 3, 2025 | VERA Vera Therapeutics, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -10,000 | $40.00 | $400k | 22,500 | Dec 4, 2025 |
| Dec 3, 2025 | VERA Vera Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 265,000 | Dec 4, 2025 |
Questions about William D. Turner
Answered from the filings on this page, as of the latest one.
Is William D. Turner buying or selling?
In the last 12 months William D. Turner reported 0 open-market buys worth $0 and 4 open-market sells worth $1.4M on SEC Form 4; the latest was sold $92k of VERA on Feb 23, 2026. Grants, option exercises and tax withholding are not counted.
How did William D. Turner's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William D. Turner has 0.
Where does William D. Turner file Form 4?
William D. Turner has filed Form 4 at VERA (Vera Therapeutics, Inc.) as Chief Regulatory Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.